Document is current
Any future updates will be listed below
-
Authors
Sheikh, Gabriel T. https://orcid.org/0000-0002-7026-9203
Delker, Astrid
Zacherl, Mathias J.
Holzgreve, Adrien
Takayama Fouladgar, Sarah L.
Unterrainer, Marcus
Rübenthaler, Johannes
Casuscelli, Jozefina
Gafita, Andrei
Unterrainer, Lena M.
-
Funding
Funding for this research was provided by:
Klinikum der Universität München
- License Information
-
More Information
Article History
Received: 18 October 2024
Accepted: 23 February 2025
First Online: 4 March 2025
Declarations
:
: This retrospective analysis was performed in compliance with the principles of the Declaration of Helsinki and its subsequent amendments and was approved by the local Ethics Committee of the LMU Medical Faculty (approval number 22–0552). Consent to participate was waived due to the retrospective nature of our study.
: Not applicable.
: Lena M. Unterrainer received personal fees from Novartis Radiopharmaceuticals, Astellas Pharma Inc., Telix Pharmaceuticals and is on the advisory board of Telix Pharmaceuticals. Adrien Holzgreve reports compensation for scientific consulting by ABX advanced biochemical compounds outside the submitted work. All other authors declare that they have no conflicts of interest or competing interests.
